Recently, dPCR has been proposed as a tool for reproducible quantification of fusion gene transcripts like BCR-ABL1 in leukemias [20] and also NPM-ALK transcripts in children with ALCL [10]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.